Ocular Therapeutix, Inc.
OCUL
$9.16
-$0.12-1.29%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -88.61M | -64.65M | -69.42M | -67.81M | -64.05M |
| Total Depreciation and Amortization | 1.28M | 1.25M | 1.07M | 1.03M | 981.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 20.37M | 11.26M | 13.90M | 11.00M | 12.87M |
| Change in Net Operating Assets | 962.00K | -2.10M | 3.73M | 552.00K | 5.53M |
| Cash from Operations | -65.99M | -54.25M | -50.73M | -55.24M | -44.67M |
| Capital Expenditure | -4.66M | -2.84M | -5.99M | -1.25M | -1.93M |
| Sale of Property, Plant, and Equipment | -- | 0.00 | 0.00 | 130.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -4.66M | -2.84M | -5.99M | -1.12M | -1.93M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 294.00K | 449.38M | 10.36M | 97.81M | 4.18M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 294.00K | 449.38M | 10.36M | 97.81M | 4.18M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -70.36M | 392.29M | -46.36M | 41.45M | -42.42M |